149 related articles for article (PubMed ID: 34411556)
1. Serum hypoxia-inducible factor 1alpha emerges as a prognostic factor for severe traumatic brain injury.
Lv QW; Zheng ZQ; Zhang H; Guo M; Shen LJ
Clin Chim Acta; 2021 Nov; 522():77-82. PubMed ID: 34411556
[TBL] [Abstract][Full Text] [Related]
2. Potential role of serum hypoxia-inducible factor 1alpha as a biomarker of delayed cerebral ischemia and poor clinical outcome after human aneurysmal subarachnoid hemorrhage: A prospective, longitudinal, multicenter, and observational study.
Cai YY; Zhuang YK; Wang WJ; Jiang F; Hu JM; Zhang XL; Zhang LX; Lou XH
Front Neurol; 2022; 13():1072351. PubMed ID: 36570456
[TBL] [Abstract][Full Text] [Related]
3. Serum Hypoxia-Inducible Factor 1alpha Levels Correlate with Outcomes After Intracerebral Hemorrhage.
Cai Y; Zhuang YK; Wu XY; Dong XQ; Du Q; Yu WH; Wang KY; Hu W; Zheng YK
Ther Clin Risk Manag; 2021; 17():717-726. PubMed ID: 34285494
[TBL] [Abstract][Full Text] [Related]
4. A prospective observational study on utility of serum mesencephalic astrocyte-derived neurotrophic factor as a promising prognostic biomarker of severe traumatic brain injury in humans.
Wang KW; Zhan CP; Liu YQ; Fu ZZ; Qiu TW; Yu GF
Clin Chim Acta; 2023 May; 545():117370. PubMed ID: 37137461
[TBL] [Abstract][Full Text] [Related]
5. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of hypoxia-inducible factor 1α and Bcl-2/adenovirus E1B19kDa-interacting protein 3 in children with traumatic brain injury].
Zhu L; Wang XC; Xu YY; Wang N; Zhu BX; Li ZW
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Apr; 26(4):378-384. PubMed ID: 38660902
[TBL] [Abstract][Full Text] [Related]
7. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.
Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J
Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776
[TBL] [Abstract][Full Text] [Related]
8. Importance of serum IRAK3 as a biochemical marker in relation to severity and neurological outcome of human severe traumatic brain injury: A prospective longitudinal cohort study.
Yang K; Yang L; Chen X; Li J; Zheng B; Hu J; Wang H; Yu Q; Song G
Clin Chim Acta; 2024 Jan; 553():117754. PubMed ID: 38169195
[TBL] [Abstract][Full Text] [Related]
9. Serum sulfonylurea receptor-1 as a biomarker of clinical severity and prognosis in patients with traumatic brain injury.
Ying X; Chen M; Zhang J; Sun CF; Zhou J
Clin Chim Acta; 2022 Mar; 528():65-73. PubMed ID: 35092725
[TBL] [Abstract][Full Text] [Related]
10. Temporal change of serum xanthine oxidase levels and its relation to clinical outcome of severe traumatic brain injury: a prospective cohort study.
Yan T; Shan H; Wang Z; Zou S; Chen Z; Yu W; Du Q; Dong X
Neurosurg Rev; 2023 Dec; 46(1):320. PubMed ID: 38038775
[TBL] [Abstract][Full Text] [Related]
11. Serum calprotectin as a prognostic predictor in severe traumatic brain injury.
Yang Y; Shen L; Xu M; Chen L; Lu W; Wang W
Clin Chim Acta; 2021 Sep; 520():101-107. PubMed ID: 34102135
[TBL] [Abstract][Full Text] [Related]
12. Elevated concentrations of hypoxia-inducible factor-1α in patients with fracture and concomitant traumatic brain injury.
Sang X; Wang Z; Qin T; Li Y
Ann Clin Biochem; 2017 Sep; 54(5):584-592. PubMed ID: 27687082
[TBL] [Abstract][Full Text] [Related]
13. Serum apelin-13 and risk of death following severe traumatic brain injury.
Zhuang Y; Wang W; Chen L; Lu W; Xu M
Clin Chim Acta; 2021 May; 516():64-68. PubMed ID: 33508251
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors of severe traumatic brain injury and the predictive value of serum translocator protein combined with the reverse shock index multiplied by Glasgow Coma Scale].
Chen X; Zhu L
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):218-223. PubMed ID: 33455149
[No Abstract] [Full Text] [Related]
15. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity.
Brennan PM; Murray GD; Teasdale GM
J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516
[TBL] [Abstract][Full Text] [Related]
16. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury.
Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y
Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319
[TBL] [Abstract][Full Text] [Related]
17. Utility of serum nuclear factor erythroid 2-related factor 2 as a potential prognostic biomarker of severe traumatic brain injury in adults: A prospective cohort study.
Yan XJ; Zhan CP; Lv Y; Mao DD; Zhou RC; Xv YM; Yu GF
Front Neurol; 2022; 13():1013062. PubMed ID: 36388174
[TBL] [Abstract][Full Text] [Related]
18. Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury.
Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Kac PR; Zetterberg H; Andersson E; Yakoub Y; Hanrieder J; Turton M; Harrison P; Nellgård B; Karikari TK; Blennow K
JAMA Netw Open; 2023 Jul; 6(7):e2321554. PubMed ID: 37399012
[TBL] [Abstract][Full Text] [Related]
19. Importance of AIM2 as a serum marker for reflecting severity and predicting a poor outcome of human severe traumatic brain injury: A prospective longitudinal cohort study.
Chen SH; Hu FL; Wang G; Liang XS; He CJ
Clin Chim Acta; 2024 Jun; 559():119691. PubMed ID: 38685373
[TBL] [Abstract][Full Text] [Related]
20. Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans.
Zhao YY; Lou L; Yang KC; Wang HB; Xu Y; Lu G; He HY
Clin Chim Acta; 2017 Sep; 472():46-50. PubMed ID: 28732652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
